Lataa...
IGFBP2/FAK pathway is causally associated with dasatinib resistance in non-small Cell Lung Cancer Cells
IGFBP2 expression is increased in various types of cancers, including in a subset of lung cancer patients. Because IGFBP2 is involved in signal transduction of some critical cancer related pathways, we analyzed the association between IGFBP2 and response to pathway-targeted agents in seven human non...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3858413/ https://ncbi.nlm.nih.gov/pubmed/24130049 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-13-0233 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|